What is the recommended treatment for impetigo in children?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Impetigo in Children

First-Line Treatment: Topical Therapy for Localized Disease

For children with localized, minor impetigo, mupirocin 2% topical ointment applied three times daily for 5-7 days is the recommended first-line treatment. 1, 2, 3

  • Mupirocin is FDA-approved specifically for impetigo caused by Staphylococcus aureus and Streptococcus pyogenes, the two primary pathogens responsible for this infection 3
  • The American Academy of Pediatrics and Infectious Diseases Society of America both endorse this as first-line therapy for superficial, localized lesions 1, 2
  • Topical therapy achieves cure rates exceeding 90% when lesions are limited and superficial 4
  • Retapamulin is an alternative topical agent if mupirocin is unavailable or has failed 5

When to Switch to Oral Antibiotics

Oral antibiotics are indicated when: 2

  • Lesions are numerous or extensive
  • Topical treatment is impractical
  • Lesions involve the face, eyelids, or mouth
  • No response to topical therapy after 3-5 days
  • Systemic symptoms are present

Oral Antibiotic Regimens

For Methicillin-Susceptible S. aureus (MSSA)

First-line oral options include: 2, 5

  • Dicloxacillin: 12 mg/kg/day divided into 4 doses for 7-10 days
  • Cephalexin: 25 mg/kg/day divided into 4 doses for 7-10 days
  • Amoxicillin-clavulanate: 25 mg/kg/day (of amoxicillin component) divided into 2 doses for 7-10 days

For Suspected or Confirmed MRSA

When MRSA is suspected (treatment failure, known local prevalence, or confirmed by culture): 1, 2, 5

  • Clindamycin: 10-13 mg/kg/dose every 6-8 hours (total 40 mg/kg/day) if local resistance rate is <10%
  • Trimethoprim-sulfamethoxazole (TMP-SMX): 8-12 mg/kg/day (based on trimethoprim component) divided into 2 doses
  • Clindamycin provides dual coverage for both MRSA and streptococci 1

Critical Pitfalls to Avoid

Penicillin alone is NOT effective for impetigo because it lacks adequate coverage against S. aureus 2, 5

Tetracyclines (doxycycline, minocycline) are absolutely contraindicated in children under 8 years of age due to risk of permanent tooth discoloration 1, 2, 5

Macrolides (erythromycin) should be used with caution due to increasing resistance rates among S. aureus strains 5, 6

When to Obtain Cultures

Bacterial cultures are recommended in: 1, 2

  • Treatment failure after 48-72 hours
  • Suspected MRSA infection
  • Recurrent infections
  • Severe local infection or systemic illness

Treatment Algorithm

  1. Assess extent of disease:

    • Limited, localized lesions → Mupirocin 2% ointment TID for 5-7 days 2, 3
    • Extensive lesions, facial involvement, or systemic symptoms → Oral antibiotics 2
  2. If oral antibiotics needed:

    • Low MRSA prevalence area → Dicloxacillin or cephalexin for 7-10 days 2, 5
    • High MRSA prevalence or treatment failure → Clindamycin (if local resistance <10%) or TMP-SMX 1, 2
  3. Reassess at 48-72 hours:

    • No improvement → Switch from topical to oral, or change oral agent based on culture results 2, 5
    • Consider MRSA coverage if not already initiated 5

Prevention and Hygiene Measures

To prevent spread and recurrence: 1, 2

  • Cover draining wounds with clean, dry bandages
  • Maintain good hand hygiene with soap and water or alcohol-based gel
  • Avoid sharing personal items (razors, linens, towels)
  • Clean high-touch surfaces regularly
  • Evaluate and treat symptomatic household contacts 1

Special Considerations for Recurrent Impetigo

For children with recurrent infections: 5, 4

  • Evaluate for nasal carriage of S. aureus
  • Consider decolonization strategies after treating active infection
  • Assess household contacts for colonization 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Non-Bullous Impetigo in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Impetigo: an overview.

Pediatric dermatology, 1994

Guideline

Treatment of Impetigo Refractory to Mupirocin

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Impetigo: diagnosis and treatment.

American family physician, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.